Sumitomo Pharma Co., Ltd.TSE 4506

住友ファーマ株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥2,084
FY ending Mar 2026
Market cap at FY-end
¥829B
Dividend per share
—
Avg. director pay
¥34.5M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Sumitomo Chemical Co., Ltd. 205,634,000 51.76% ¥429B —
2 日本マスタートラスト信託銀行株式会社 25,038,000 6.30% ¥52.2B —
3 株式会社SMBC信託銀行 7,000,000 1.76% ¥14.6B —
4 株式会社日本カストディ銀行 6,219,000 1.57% ¥13.0B —
5 住友生命保険相互会社 5,776,000 1.45% ¥12.0B —
6 BNY Mellon as Agent/Clients 10 Percent 4,573,000 1.15% ¥9.5B —
7 Inabata & Co., Ltd. 4,400,000 1.11% ¥9.2B —
8 THE BANK OF NEW YORK, TREATY JASDEC ACCOUNT 3,977,000 1.00% ¥8.3B —
9 日本生命保険相互会社 3,790,000 0.95% ¥7.9B —
10 J.P. MORGAN BANK LUXEMBOURG S.A. 381593 3,030,000 0.76% ¥6.3B —

Officers' holdings and pay

NameTitleSharesValuePay
木村 徹 President & Representative Director 105,000 ¥219M —
酒井 基行 Executive Vice President & Representative Director 14,000 ¥29.2M —
中川 勉 Director 9,000 ¥18.8M —
新沼 宏 Director — — —
碓井 稔 Outside Director — — —
藤本 康二 Outside Director — — —
加島 久宜 Director 19,000 ¥39.6M —
射手矢 好雄 Outside Director — — —
望月 眞弓 Outside Director — — —
道盛 大志郎 Outside Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥2,084 ¥289.41 7.2x — 397,900,000
FY ending Mar 2025 ¥722 ¥267.28 2.7x — 397,900,000
FY ending Mar 2024 ¥722 ¥-1,480.32 — — 397,900,000
FY ending Mar 2023 — ¥-460.52 — ¥21.0 397,900,000
FY ending Mar 2022 ¥1,212 ¥147.81 8.2x ¥28.0 397,900,000
FY ending Mar 2021 ¥1,935 ¥293.23 6.6x ¥28.0 397,900,000
FY ending Mar 2020 ¥1,395 ¥253.64 5.5x ¥28.0 397,900,000
Source: annual securities reports on EDINET. Values are estimates. Methodology